Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$980M |
| 2 |
Humana
HUM
|
+$637M |
| 3 |
Apple
AAPL
|
+$620M |
| 4 |
Home Depot
HD
|
+$541M |
| 5 |
Microsoft
MSFT
|
+$539M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$770M |
| 2 |
McDonald's
MCD
|
+$654M |
| 3 |
Cigna
CI
|
+$498M |
| 4 |
Digital Realty Trust
DLR
|
+$430M |
| 5 |
Amazon
AMZN
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.91% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2% |
| 4 | Industrials | 1.79% |
| 5 | Financials | 1.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STLN
11451
Starling Oncology
STLN
$657M
| $59.8K | ﹤0.01% |
+42,717
| New | +$44.2K |
|
11452
PUT
iShares MSCI Emerging Markets ex China ETF
EMXC
$24.7B
| $59.8K | ﹤0.01% |
1,200
-700
| -37% | -$36.3K |
|
|
NIU
11453
PUT
Niu Technologies
NIU
$163M
| $59.7K | ﹤0.01% |
21,100
+8,700
| +70% | +$30.3K |
|
11454
PUT
State Street SPDR Portfolio TIPS ETF
SPIP
$1.01B
| $59.6K | ﹤0.01% |
2,400
-4,000
| -63% | -$101K |
|
11455
Jerash Holdings
JRSH
$67.3M
| $59.6K | ﹤0.01% |
+19,794
| New | +$69K |
|
11456
Enlivex Ltd
ENLV
$26.6M
| $59.5K | ﹤0.01% |
2,512
-62
| -2% | -$2.15K |
|
11457
PUT
National Bank Holdings
NBHC
$1.94B
| $59.5K | ﹤0.01% |
+2,000
| New | +$64.1K |
|
11458
AEON Biopharma
AEON
$13.4M
| $59.4K | ﹤0.01% |
+147
| New | +$67.3K |
|
|
SGMO
11459
PUT
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $59.4K | ﹤0.01% |
99,000
+55,300
| +127% | +$59.2K |
|
11460
PUT
OceanFirst Financial
OCFC
$1.91B
| $59.3K | ﹤0.01% |
4,100
-8,500
| -67% | -$143K |
|
11461
PUT
Traeger
COOK
$164M
| $59.2K | ﹤0.01% |
434
-140
| -24% | -$29.7K |
|
11462
SelectQuote
SLQT
$129M
| $59.2K | ﹤0.01% |
50,603
+47,179
| +1,378% | +$71.2K |
|
11463
PUT
KraneShares Bosera MSCI China A 50 Connect Index ETF
KBA
$147M
| $59.1K | ﹤0.01% |
2,600
-800
| -24% | -$18.8K |
|
11464
PUT
Community Bank
CBU
$3.46B
| $59.1K | ﹤0.01% |
1,400
-2,000
| -59% | -$94.8K |
|
11465
Trevi Therapeutics
TRVI
$2.63B
| $59K | ﹤0.01% |
27,081
-33,372
| -55% | -$75.4K |
|
|
GB
11466
CALL
DELISTED
Global Blue Group Holding
GB
| $59K | ﹤0.01% |
9,700
-4,100
| -30% | -$21.8K |
|
11467
AirSculpt Technologies
AIRS
$247M
| $58.9K | ﹤0.01% |
+8,615
| New | +$69K |
|
11468
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.76B
| $58.9K | ﹤0.01% |
1,273
-200
| -14% | -$9.56K |
|
|
NGD
11469
CALL
DELISTED
New Gold Inc
NGD
| $58.7K | ﹤0.01% |
64,500
+5,700
| +10% | +$6.07K |
|
11470
SEALSQ Corp
LAES
$671M
| $58.6K | ﹤0.01% |
+28,873
| New | +$227K |
|
|
PKST
11471
DELISTED
Peakstone Realty Trust
PKST
| $58.6K | ﹤0.01% |
+3,522
| New | +$74.8K |
|
11472
SOPHiA GENETICS
SOPH
$638M
| $58.6K | ﹤0.01% |
22,979
-23,710
| -51% | -$75.2K |
|
11473
PUT
RxSight
RXST
$287M
| $58.6K | ﹤0.01% |
2,100
-1,300
| -38% | -$38.8K |
|
11474
CPI Aerostructures
CVU
$77.6M
| $58.5K | ﹤0.01% |
17,514
-17,960
| -51% | -$66.2K |
|
|
DADA
11475
DELISTED
Dada Nexus
DADA
| $58.5K | ﹤0.01% |
13,136
-348,911
| -96% | -$1.86M |
|
Similar funds
Ken Griffin's Q3 2023 Portfolio in Review
As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.
By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
- Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
- Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
- Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
- Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
- Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
- Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.
Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.